0001225208-21-010280.txt : 20210706
0001225208-21-010280.hdr.sgml : 20210706
20210706161247
ACCESSION NUMBER: 0001225208-21-010280
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210701
FILED AS OF DATE: 20210706
DATE AS OF CHANGE: 20210706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WICHMANN DAVID S
CENTRAL INDEX KEY: 0001268489
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 211074207
MAIL ADDRESS:
STREET 1: UNITEDHEALTH GROUP INC
STREET 2: 9900 BREN RD E
CITY: MINNETONKA
STATE: MN
ZIP: 55343
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2021-07-01
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001268489
WICHMANN DAVID S
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
Deferred Stock Units
2021-07-01
4
A
0
4093.0000
0.0000
A
Common Stock
4093.0000
4093.0000
D
Deferred Stock Units
2021-07-01
4
A
0
2296.0000
0.0000
A
Common Stock
2296.0000
6389.0000
D
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Reflects a value of approximately $177,500 (representing the prorated amount of the non-employee director compensation program's annual equity grant having a value of $205,000) divided by the closing price of common stock on the date of grant.
Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2022 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
Reflects a value of approximately $99,600 (representing the prorated amount of the non-employee director compensation program's cash retainer having a value of $115,000) divided by the closing price of the common stock on the date of grant.
Grant of deferred stock units in lieu of yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2022 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan.
/s/ Mai-Khoi Nguyen-Thanh, Attorney-in-Fact
2021-07-06